Back

On the use of Isosorbidedinitrate and Hydralazine for heart failure in patients of African ancestry in the Netherlands

29 August 2017 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 7 - Chronic heart failure (CHF) Pharmacologic therapy ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Fares Karamat

Amphia Hospital, Breda (Netherlands (The))

29 More presentations in this session

Presentation thumbnail
Doctor M. Koga (Osaka, JP)
Abstract
Presentation thumbnail
Doctor P. Kanagala (Liverpool, GB)
Abstract Slides
Presentation thumbnail
Associate Professor S. Caravita (Bergamo, IT)
Abstract
Presentation thumbnail
Doctor K. Keramida (Athens, GR)
Abstract Slides
Presentation thumbnail
Professor P. Leszek (Warsaw, PL)
Abstract Slides

Access the full session

Session thumbnail
Poster session 7 - Chronic heart failure (CHF)

The Event

Event poster

ESC Congress 2017

29 August 2017 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Efficacy and safety of dapagliflozin in black, compared to white, patients with heart failure with reduced ejection fraction: Results from DAPA-HF
29 June 2021
thumbnail
Congress Session
Implementation of heart failure therapy: different approaches in the Netherlands and Norway
27 August 2023
thumbnail
Congress Presentation
Current practices and perspectives on the use of intravenous vasodilators in acute heart failure: an international survey.
14 March 2025
thumbnail
Congress Presentation
Genetic profile and prognosis of non-ischemic dilated cardiomyopathies in afro-caribeans
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources